Cardiogenetics (Mar 2022)

MYH7 Genotype–Phenotype Correlation in a Cohort of Finnish Patients

  • Teemu Vepsäläinen,
  • Tiina Heliö,
  • Catalina Vasilescu,
  • Laura Martelius,
  • Sini Weckström,
  • Juha Koskenvuo,
  • Anita Hiippala,
  • Tiina Ojala

DOI
https://doi.org/10.3390/cardiogenetics12010013
Journal volume & issue
Vol. 12, no. 1
pp. 122 – 132

Abstract

Read online

Cardiomyopathies (CMPs) are a heterogeneous group of diseases, frequently genetic, affecting the heart muscle. The symptoms range from asymptomatic to dyspnea, arrhythmias, syncope, and sudden cardiac death. This study is focused on MYH7 (beta-myosin heavy chain), as this gene is commonly mutated in cardiomyopathy patients. Due to the high combined prevalence of MYH7 variants and severe health outcomes, it is one of the most frequently tested genes in clinical settings. We analyzed the clinical presentation and natural history of 48 patients with MYH7-related cardiomyopathy belonging to a cohort from a tertiary center at Helsinki University Hospital, Finland. We made special reference to three age subgroups (0–1, 1–12, and >12 years). Our results characterize a clinically significant MYH7 cohort, emphasizing the high variability of the CMP phenotype depending on age. We observed a subgroup of infants (0–1 years) with MYH7 associated severe DCM phenotype. We further demonstrate that patients under the age of 12 years have a similar symptom burden compared to older patients.

Keywords